Scientific Sessions 2025  /  Controversies in Lifetime Management of Aortic Stenosis Patients Under 65 years: TAVR vs SAVR First Strategy  /  Case Presentation: Low-Risk Young (50-60 Years Old) Patient with Severe Symptomatic Aortic Stenosis
Logo

American Heart Association

  35
  0

Final ID:

Case Presentation: Low-Risk Young (50-60 Years Old) Patient with Severe Symptomatic Aortic Stenosis

  • Hamilton, Barbara  ( University of Michigan , Ann Arbor , Michigan , United States )
  • Scrimgeour, Laura  ( Brigham and Women's Hospital , Boston , Massachusetts , United States )
  • Bromberger, Bianca  ( UCSF , Boston , Massachusetts , United States )
  • Boskovski, Marko  ( UCSF , Boston , Massachusetts , United States )
    • Author Disclosures:
    Barbara Hamilton: DO NOT have relevant financial relationships | Laura Scrimgeour: DO NOT have relevant financial relationships | Bianca Bromberger: No Answer | Marko Boskovski: DO have relevant financial relationships ; Consultant:Edwards Lifesciences:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Controversies in Lifetime Management of Aortic Stenosis Patients Under 65 years: TAVR vs SAVR First Strategy

Saturday, 11/08/2025 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts on this topic:
Redo TAVR in TAVR vs Need for TAVR Explantation

Kaneko Tsuyoshi, Fukuhara Shinichi, Bapat Vinayak, Arnaoutakis George, Ouzounian Maral

Survival Is Key: Ross Operation

El-hamamsy Ismail, Boskovski Marko, Tseng Elaine

More abstracts from these authors:
Case Presentation: LIfetime Management in 65-79 Year Olds

Hamilton Barbara, Scrimgeour Laura, Bromberger Bianca

Case Presentation: TAVR Degeneration in an Intermediate-Risk Patient

Hamilton Barbara, Scrimgeour Laura, Bromberger Bianca

You have to be authorized to contact abstract author. Please, Login
Not Available